The Ocular Genetics Program: Multidisciplinary care of patients with ocular genetic eye disease

Canadian Journal of Ophthalmology

Volumn 42, Issue 5, 2007, Pages 734-738

  Morad, Yair ^a   Sutherland, Joanne ^a   DaSilva, Lisa ^a   Ulster, Alissa ^a   Shik, John ^a   Gallie, Brenda ^a   Héon, Elise ^a   Levin, Alex V ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Eye disease; Inherited eye disorder; Multidisciplinary; Ocular genetics

Indexed keywords

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EYE DISEASE; EYE EXAMINATION; GENETIC ANALYSIS; GENETIC DISORDER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PATIENT SATISFACTION; VISUAL FIELD;

EID: 36349035021     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-144     Document Type: Article

References (11)

1. McKusick VA. Inheritance in Man. A Catalog of Human Genes and Genetic Diseases. Baltimore: University Press; 1994:260-1.
2. Hurst JA. Genetics of blindness. Br J Hosp Med 1992;47(7):495-500.
3. MacDonald IM, Mah DY. Summary of heritable ocular disorders and selected systemic conditions with eye findings. Ophthalmic Genet 2000;21(1):29-49.
4. Foundation Fighting Blindness. Foundation Fighting Blindness Guide to Retinitis Pigmentosa and Related Conditions. Toronto: Foundation Fighting Blindness; 2006.
5. Sutherland J. The biology behind genetic counselling. Toronto, Ont.: The Hospital for Sick Children; 1997. Available at: http://www.sickkids. ca/ophthalmology/custom/biologybehind-geneticcounselling.pdf. Accessed November 16, 2006.
6. Sevilla C, Julian-Reynier C, Eisinger F, et al. Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. Int J Technol Assess Health Care 2003;19(2):287-300.
7. Higashi MK, Veenstra DL. Managed care in the genomics era: assessing the cost effectiveness of genetic tests. Am J Manag Care 2003;9(7):493-500.
8. Noorani HZ, Khan HN, Gallie BL, Detsky, AS. Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet 1996;59(2):301-7.
9. Wallace JY, Zhou GN, Usmani M, et al. BARCODE-ALL: acceletated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays. Leukemia 2003;17(7):1404-10.
10. Reyes CM, Allen BA, Terdiman JP, Wilson LS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 2002;95(9):1848-56.
11. Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-69.